| 000 | 01381 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250518093420.0 | ||
| 264 | 0 | _c20210119 | |
| 008 | 202101s 0 0 eng d | ||
| 022 | _a2168-6114 | ||
| 024 | 7 |
_a10.1001/jamainternmed.2020.0338 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJensen, Thomas Bo | |
| 245 | 0 | 0 |
_aShift From Adalimumab Originator to Biosimilars in Denmark. _h[electronic resource] |
| 260 |
_bJAMA internal medicine _c06 2020 |
||
| 300 |
_a902-903 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdalimumab _xeconomics |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xeconomics |
| 650 | 0 | 4 |
_aBiosimilar Pharmaceuticals _xeconomics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDenmark |
| 650 | 0 | 4 | _aDrug Costs |
| 650 | 0 | 4 | _aDrug Substitution |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aKim, Seoyoung C | |
| 700 | 1 | _aJimenez-Solem, Espen | |
| 700 | 1 | _aBartels, Dorthe | |
| 700 | 1 | _aChristensen, Hanne Rolighed | |
| 700 | 1 | _aAndersen, Jon Trærup | |
| 773 | 0 |
_tJAMA internal medicine _gvol. 180 _gno. 6 _gp. 902-903 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamainternmed.2020.0338 _zAvailable from publisher's website |
| 999 |
_c30794976 _d30794976 |
||